KCT0003568
Not yet recruiting
未知
A study to assess the occurrence of metabolic diseases associated with the use of antipsychotic drugs in Korean schizophrenia patients based on the national health insurance database
Kyung Hee University Hospital0 sites10,000 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kyung Hee University Hospital
- Enrollment
- 10000
- Status
- Not yet recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Patients who were registered in the National Health Insurance database, and whose data (from the time of diagnosis to 2015\) can be used for the analysis.
- •2\)Patients who were diagnosed as schizophrenia in 2008\-2010 (patients with the F20 code of International Classification of Diseases, 10th Revision (ICD\-10\)).
Exclusion Criteria
- •1\) Patients who can not be included in the analysis due to missing information of demographics (date of birth, gender, age, etc.) diseases (i.e., name of disease), or prescription (i.e., name of prescribed drug)
- •2\) In the case of patients who were treated with clozapine, the data cannot be included in the analysis when the information required for the analysis (e.g., drug information, average daily dose, total number of days of administration, and so on) is missing.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Risk of metabolic syndrome in male patients with early onset male pattern hair lossCTRI/2022/01/039509Department of Dermatology St Johns Medical College
Not yet recruiting
Not Applicable
A study to assess the endogenous metabolic alterations and pharmacokinetic·pharmacodynamic characteristics after oral administrations of dapagliflozin in healthy and obese adult volunteersEndocrine, nutritional and metabolic diseasesKCT0007864Kyungpook National University Hospital30
Recruiting
Phase 3
Effect of sitagliptin on metabolic abnormalities in schizophrenic patients treating with olanzapineIRCT20191210045677N1Shiraz University of Medical Sciences80
Not yet recruiting
Not Applicable
Prevalence of Metabolic Syndrome among young adultsCTRI/2023/11/059989Imlinungla
Recruiting
Not Applicable
MAFLD and Sarcopenia and heart disease riskCTRI/2022/04/042201ICMR